A new study led by researchers at National Jewish Health provides quantitative evidence linking burn pit smoke exposure during military deployment to increases in harmful carbon-based particles in the ...

Management of Essential Tremor prioritizes functional improvement over symptom elimination, and protocols begin with ...

Pulmonary hypertension life expectancy and prognosis can vary broadly, but have improved in the era of modern treatment.

Higher levels of fetal hemoglobin may guard against lung problems and delay bone damage in people with sickle cell disease, ...

In ‘Made in SG’ Melanie Oliveiro profiles the locally founded Pulmonary Hypertension Support Group (PHSG), a patient support ...

Although more women than men have pulmonary arterial hypertension, several PAH medications are teratogenic, according to a ...

Pulmonary hypertension (PH) has a high mortality rate if untreated. Unfortunately, the disease is not consistently diagnosed or treated across the United States. To improve the diagnosis and care of ...

Estimated YUTREPIA net product sales of approximately $90.1 million in the fourth quarter and $148.3 million for full-year 2025Received more than 2,800 unique patient prescriptions since launch in Jun ...

Estimated YUTREPIA™ net product sales of approximately $90.1 million in the fourth quarter and $148.3 million for full-year ...

Proceeds to fund clinical development of DIAG723, a first-in-class, disease-modifying therapy designed to correct the root cause of hereditary hemorrhagic telangiectasia and pulmonary arterial ...

Findings reinforce brilaroxazine’s treatment effect on negative symptoms and other symptom domains in schizophrenia and support ...

Reduced diffusing capacity of the lungs for carbon monoxide (DLco) reflects microvasculopathy in chronic thromboembolic ...